Medical and Pharmaceutical Industry - Market Research Report

  The global night creams market size was valued at USD 9.72 billion in 2023 and is anticipated to grow at a CAGR of 6.2% from 2024 to 2030. Increasing consumer awareness about skincare and the benefits of night creams is a significant driver. As more people prioritize their skincare routines, the demand for specialized products such as night creams has surged. In addition, the rise in disposable income, especially in emerging economies, allows consumers to spend more on premium skincare products. The growing influence of social media and beauty influencers also plays a crucial role in promoting night creams, making them more popular among younger demographics.  There is a strong shift towards products with natural and organic ingredients as consumers become more health-conscious and environmentally aware. There’s also a growing demand for multifunctional night creams that offer benefits beyond hydration, such as anti-aging, brightening, and skin repair. The market is expected...

  The global microarray market size is expected to reach USD 8.50 billion by the year 2030, growing at a CAGR of 6.6%, according to a new report by Grand View Research, Inc. Market drivers propelling market growth include a global rise in cancer cases and a wide range of applications of microarrays in sequencing, genome mapping, personalized medicines, and others. A rise in global R&D investments is also key in propelling growth as this would lead to a rise in the use of microarrays for research purposes to advance and improve in healthcare. Microarrays have a wide range of applications such as research applications, drug discovery, disease diagnosis, genomic and proteomic research, plant and food research, agricultural research, among other applications. According to a report published by the American Academy of Neurology, chromosomal microarray analysis can be used to diagnose intellectual disabilities and disomic features, this test has also been recommended as a first line ...

  The global metabolic disorder therapeutics market size is expected to reach USD 120.71 billion by 2030, registering a CAGR of 7.8% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising incidences of diabetes, obesity, and hypercholesterolemia are expected to drive the market growth. It is estimated that by 2040, about 1 person in 11 people worldwide is likely to suffer from one of the aforementioned diseases. Researchers estimate that the prevalence of metabolic diseases like obesity and diabetes is expected to double in the coming 2 decades, mainly in U.S. and Asian and Latin American countries. This, in turn, will help boost the overall market growth in the year to come. Furthermore, with better economic stability in developing countries, demand for novel therapeutics for one-time treatment has increased. This has made major companies in the global market to invest heavily in R&D to develop innovative therapy options. All these factors will contri...

  The global medical thawing system market size is expected to reach USD 355.9 million by 2030, registering a CAGR of 8.3% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growing demand for medical thawing systems in blood banks and laboratories, where it requires warming of products such as crystalloid infusion solution, whole blood, and RBC before transfusion into a patient, is expected to drive the growth. Technological advancements in automated thaw systems at the point of care settings and rising demand for rapid thawing techniques of frozen plasma in various surgical procedures are the factors augmenting the market growth. Besides, the rising use of thawed cells due to the high incidence of road accidents, diabetes, cancer, and trauma cases are also creating demand. The rising number of surgical procedures and increasing incidence of hemorrhage related conditions in these surgical procedures are driving the healthcare thawing system market growth...

  The global medical document management systems market size is expected to reach USD 1.33 billion by 2030, according to a new report by Grand View Research, Inc. The global market is estimated to register a CAGR of 11.9% from 2024 to 2030. The sector has experienced noticeable growth in the past few years owing to rising burden of paper management and storage. Medical document management solutions such as hospital information systems, patient monitoring system, Electronic Medical Record (EMR), and e-prescribing methods facilitate managing medical records like insurance cards/claims, admission forms, invoices, and records of laboratory results. Rising need for ease of managing large amounts of healthcare data along with increasing demand for Electronic Health Record (EHR) and Clinical Trial Management System (CTMS) is expected to propel market demand. Various government initiatives to develop healthcare IT and clinical document managing software sector globally are the key drivers ...

  The global local anesthesia drugs market size is anticipated to reach USD 5.14 billion in 2030 and is projected to grow at a CAGR of 3.6% from 2024 to 2030. The rising number of surgical procedures across the globe, including cosmetic surgeries, dental procedures, and plastic surgeries, is driving the growth of local anesthetics. There has been a considerable increase in the number of surgical procedures requiring post-operative pain relief and this trend is expected to continue throughout the forecast period. Roughly, 65.0% of total surgical procedures require post-operative pain management. This is likely to boost the demand for local anesthesia drugs. The introduction of new and effective drugs such as levobupivacaine, articaine, and ropivacaine is also driving the growth of the local anesthesia drugs market across the globe. Rising healthcare expenditure in developing countries is expected to result in an increase in the number of surgeries performed in countries such as Indi...

  The Latin America in vitro diagnostics market size is expected to reach USD 5.2 billion by 2030, declining at a CAGR of 1.6% from 2023 to 2030, according to a new report by Grand View Research, Inc. The Latin America IVD market is expected to grow at a significant CAGR till 2024 owing to the rising prevalence of target disorders, aging population, and the presence of favorable government initiatives for early disease diagnosis. Other factors that are anticipated to boost the growth include the introduction of technologically advanced instruments and the increasing R&D initiatives for the development of disease-specific kits. Regular testing for diabetes, cardiovascular, cancer, and sexually transmitted diseases are necessary for the timely treatments, further avoiding the risk of fatal health complications. The availability of tests for home and near patient testing is estimated to further enhance the usage rates of these devices. From November 2015, the Anvisa, which is a re...

  The global induced pluripotent stem cells production market size is expected to reach USD 2.76 billion by 2030, registering a CAGR of 9.44% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increase in demand for induced pluripotent stem cells (iPSCs) in comparison to Embryonic Stem Cells (ESCs) has offered a significant drive to the market. Advantages such as no stem cell-related ethical issues, personalized treatment, and flexibility during cell-based research have created a favorable scenario for market growth. In addition, the prevalence of chronic disorders is also driving the growth of the induced pluripotent stem cells production market, as conditions like heart disease, stroke, diabetes, and many more can be treated by utilizing iPSCs-mediated therapy. For example, according to the International Diabetes Federation (IDF), 537 million people are already living with diabetes in 2021. The rising research activities during COVID-19 pandemic have po...

  The global healthcare analytical testing services market size is expected to reach USD 25.47 billion by 2030, expanding at a CAGR of 8.36% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing outsourcing of healthcare analytical testing services, growing demand for biosimilars, and rising number of clinical trials are some of the key factors that are driving the industry's growth. In addition, the COVID-19 pandemic contributed to the growth of the industry. Biosimilars are medications that have received FDA approval and share many biologic medicines’ approved features. When compared to biologics, they are a more affordable and effective treatment alternative, and it is projected that this will significantly increase demand in the coming years. Analytical testing is highlighted as a crucial step in the development of biosimilars in a Sandoz International GmbH article, which increases demand for such services. The global COVID-19 pandemic is expe...

  The global gynecological devices market size is expected to reach USD 18.1 billion by 2030, according to a new report by Grand View Research. It is expected to register a CAGR of 8.64% from 2023 to 2030. The rising women population, growing awareness regarding early diagnosis, and available treatments for gynecological disorders are anticipated to boost the growth of the industry. The rising adoption of gynecological procedures is estimated to boost product demand over the forecast period. According to the National Center for Health Statistics, in the U.S., cesarean deliveries accounted for 31.8% of the total deliveries in 2020 when compared with vaginal deliveries. A rise in the number of these procedures, increasing awareness, and growing disposable income are expected to drive the industry. Early disease detection is imperative in devising treatment schedules. Pertinent government and regulatory agencies in collaboration with the above factors are now focusing majorly on impro...

The global epilepsy monitoring devices market size was estimated at USD 559.0 million in 2023 and is projected to grow at a CAGR of 6.6% from 2024 to 2030. The market is driven by several factors, such as the increasing prevalence of epilepsy, advances in technology, growing demand for ambulatory monitoring, rising use of wearable devices, and growing government initiatives. Further, the increasing need for improved diagnosis and treatment, growing competition, and growing importance of telemedicine are also some of the primary factors fueling the market growth. The prevalence of epilepsy is increasing globally, with a significant number of people affected worldwide. Epilepsy is a neurological disorder that affects an estimated 50 million people worldwide, making it one of the most common chronic conditions globally, according to the World Health Organization (WHO). According to the same report, around 80% of people with epilepsy live in low- and middle-income countries (LMIC), where a...

  The global disposable EEG electrode market size is expected to reach USD 921.3 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 3.6% from 2021 to 2028. Increasing cases of HAIs, technological advancements, and rising prevalence of neurological disorders and Acute Ischemic Stroke (AIS) are the key driving factors for the market. Stroke is the most common cause of death, followed by heart and cancer diseases worldwide. For instance, according to the WHO, in 2016, 15.2 million deaths of the 56.9 million deaths worldwide were due to stroke. Acute Ischemic Stroke (AIS) is the most common form of stroke, caused due to reduced blood supply to the brain, making brain cells die. For instance, according to U.S. CDC, 87.0% of strokes are classified as ischemic strokes, with the U.S. being the most commonly affected country. According to Southwestern Medical Center, about 795,000 people in the U.S. suffer from a stroke ever...

  The global dialysis chairs market size is anticipated to reach USD 117.91 million by 2030 and is anticipated to expand at a CAGR of 4.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing prevalence of kidney diseases, technological advancements in dialysis equipment, rising geriatric population, and growing demand for home-based dialysis treatment options. These factors are contributing to the overall growth and demand for dialysis chairs, is anticipated to boost the market growth. The growing number of dialysis centers is a major driver of the dialysis chairs market, as it increases the demand for dialysis treatments. For instance, as per a report by The Forum of ESRD Networks, in June 2024, The 18 ESRD Networks oversee 7,578 dialysis centers and 226 transplant centers across the U.S. and its territories. With each new center that opens, there's an immediate need for essential equipment, including dialysis chairs. This surge in facilities not o...

  The global anticoagulant reversal drugs market size is expected to reach USD 2.78 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 12.3% from 2025 to 2030. The rising number of bleeding disorders, the introduction of new drugs, and the growing number of cases requiring anticoagulant therapies are some of the factors anticipated to foster market growth during the forecast period. In October 2015, Praxbind (idarucizumab) by Boehringer Ingelheim Pharmaceuticals was approved as an anticoagulant reversal drug indicated for patients treated with Pradaxa (dabigatran) during emergency surgery or uncontrolled or life-threatening bleeding. Hence, the availability of these anticoagulation reversal drugs allows doctors and patients to consider such treatment options with greater confidence, therefore boosting the demand for anticoagulant reversal drugs. Bleeding disorders like hemophilia can be acquired or inherited. However, other...

  The global amniocentesis needle market size is anticipated to reach USD 297.35 million by 2030, expanding at a CAGR of 6.85%, based on a new report by Grand View Research, Inc. This growth can be attributed to several factors like advancements in healthcare technology, a rising prevalence of genetic disorders prompting increased demand for prenatal diagnosis, and the continuous development of minimally invasive techniques. Amniocentesis needles are in high demand as they are essential for identifying potential risks. However, there is a pressing concern within the fields of obstetrics and gynecology regarding early pregnancy loss following amniocentesis. The rise in genetic disorders worldwide is significantly boosting the demand for precise tools such as amniocentesis needles in prenatal diagnostics. This rising prevalence of genetic conditions highlights the pressing need for accurate and early detection methods for potential issues in unborn babies. The importance of advanced ...

  The global allergy diagnostics and therapeutics market size was estimated at USD 58.31 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 8.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing incidences of allergic diseases, coupled with demand for advanced therapeutics, is expected to drive the market growth in the coming years. According to estimates published by the American Academy of Allergy Asthma & Immunology (AAAAI), allergic rhinitis affects approximately 10-30% of the global population, thereby impacting the adoption of allergy therapeutics globally. The increasing integration of technologically advanced products, such as the use of artificial intelligence technology to advance treatment outcomes and manage diseases, helps practitioners in the decision-making process. Furthermore, the rising adoption of mHealth apps for diagnosing allergies such as rhinitis is expected to boost the market. For inst...